Quantitative high-throughput efficacy profiling of approved oncology drugs in inflammatory breast cancer models of acquired drug resistance and re-sensitization
Kevin P. Williams(University of North Carolina at Chapel Hill), Gayathri R. Devi(Medical University of South Carolina)
Cited by 31
Related Papers
Disulfiram (DSF) acts as a copper ionophore to induce copper‐dependent oxidative stress and mediate anti‐tumor efficacy in inflammatory breast cancer
|Molecular Oncology|2015|237
MLH1 expression sensitises ovarian cancer cells to cell death mediated by XIAP inhibition
|British Journal of Cancer|2009|28